Alzheimer's Project HBO Documentary - Chapter 3: Caregivers [gr jr] avi

The Alzheimer's Project HBO Documentary Chapter 3 - Caregivers xvid-mp3 Spoken in English Subtitles: Brazilian Portuguese See information above in English and Brazilian Portuguese see more/saiba mais: http://www.hbo.com/alzheimer http://www.hbo-br.tv/alzheimer Seed, please!! ***************************************************************************** One of the most devastating forms of memory loss is Alzheimer's disease, an irreversible and progressive brain disorder that slowly destroys memory and thinking skills. Today, Alzheimer's is the second most-feared illness in America, following cancer, and may affect as many as five million Americans. As the baby-boom generation moves through retirement, that number could soar to more than 11 million by 2040, and have a huge economic impact on America's already fragile healthcare system. While there is no cure for the disease, THE ALZHEIMER'S PROJECT shows there is now genuine reason to be optimistic about the future. Created by the award-winning team behind HBO's acclaimed "Addiction" project, this multi-platform series takes a close look at groundbreaking discoveries made by the country's leading scientists, as well as the effects of this debilitating and fatal disease both on those with Alzheimer's and on their families. Scientific research is gaining momentum in discovering ways to treat and possibly prevent Alzheimer's. Aiming to bring a new understanding, THE ALZHEIMER'S PROJECT features a four-part documentary series, 15 short supplemental films, a robust website, and a nationwide community-based information and outreach campaign. A book published by Public Affairs Books was developed by the producers as a companion to the project. HBO will use all of its platforms, including the HBO main service, multiplex channels, HBO On Demand, HBO Podcasts, hbo.com, HBO Channel onand DVD sales to support the project. In addition, all films will stream free of charge on hbo.com and will be offered for free on multiple platforms by participating television service providers. "The Alzheimer's research community welcomed the opportunity to collaborate with HBO, seeking to raise new awareness and understanding of this devastating disease," says Richard J. Hodes, M.D., director of the National Institute on Aging, the component of the National Institutes of Health leading the federal Alzheimer's disease research program. "There is a compelling story to tell of scientific discovery, of research advances and challenges, and of the human faces behind the disease." The first of the four documentaries in THE ALZHEIMER'S PROJECT is "The Memory Loss Tapes", which provides an up-close and personal look at seven individuals living with Alzheimer's, across the full spectrum of the progression of the disease. "Momentum In Science" is a two-part state-of-the-science film that takes viewers inside the laboratories and clinics of 25 leading scientists and physicians, revealing some of the most cutting-edge research advances. "'Grandpa, Do You Know Who I Am?' with Maria Shriver" captures what it means to be a child or grandchild of one with Alzheimer's, while "Caregivers" highlights the sacrifices and successes of people who experience their loved one's descent into dementia. THE ALZHEIMER'S PROJECT is a presentation of HBO Documentary Films and the National Institute on Aging at the National Institutes of Health in association with the Alzheimer's Association®, Fidelity® Charitable Gift Fund, and Geoffrey Beene Gives Back® Alzheimer's Initiative. The series' producer is John Hoffman; the executive producers are Sheila Nevins and Maria Shriver. ******************************************************************************* What Is It? * Font Size * Bookmark * Email * Share * Print Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and other thinking skills, and eventually even the ability to carry out the simplest tasks. Ultimately, the person with AD dies, often years earlier than he/she would have otherwise. In most people with AD, symptoms first appear after age 60. The brains of people with AD have an abundance of two abnormal structures—amyloid plaques and neurofibrillary tangles. A third characteristic change is the loss of connections between nerve cells (neurons) in the brain. Learn more. Who Gets It? Alzheimer's disease becomes more common as people get older. Today it affects more than 5.3 million Americans, according to estimates from the Alzheimer's Association. As the baby-boom generation moves through retirement, that number could soar to more than 11 million by 2040. One out of eight people age 65 or older has Alzheimer's. The number of people with the disease doubles for every 5-year age interval beyond age 65. Learn more. Who Is At Risk? Age is the best established risk factor for Alzheimer's. The genetic make-up inherited from parents may also influence risk of developing the disease, and when. Other non-genetic, environmental, or lifestyle factors might play a role in brain health and the development or prevention of Alzheimer's disease. Many of these can be controlled or mitigated, including physical activity, diet, control of chronic diseases, social engagement, and intellectual stimulation. Learn more. How Can People Find Out If They Have It? People who are concerned about a serious memory problem should talk with their doctor. The doctor may be able to diagnose the problem or make a referral to a specialist in neurology or geriatric psychiatry. Health care professionals who specialize in Alzheimer's can recommend ways to manage the problem or suggest treatment or services that might help. Learn more. Can It Be Treated? There is no cure for Alzheimer's disease, but current treatments focus on helping people maintain mental function, manage behavioral symptoms, and slow or delay symptoms. Four medications are approved by the U.S. Food and Drug Administration to treat AD. These drugs don't change the underlying disease process and may help only for a few months to a few years. Behavioral symptoms may accompany memory problems and can include sleeplessness, agitation, wandering, anxiety, anger, and depression. Scientists are studying new treatments to manage them. Treating behavioral symptoms often makes people with AD more comfortable and makes their care easier for caregivers. Learn more. Who Else Is Affected? There are nearly 10 million Americans providing 8.5 billion hours of unpaid care to people with Alzheimer's disease or other dementias - time valued at $94 billion, according to the Alzheimer's Association. Seventy percent of people with Alzheimer's live at home, cared for by family and friends. The largest group of family caregivers is spouses, followed by daughters, daughters-in-law, sons, siblings, and grandchildren. About three in five caregivers say their children aged 8 to 21 are involved in caring for a loved one with Alzheimer's disease, according to a 2008 Harris Interactive poll. In addition to the families and friends, our society as a whole is affected. Today, the direct costs to Medicare and Medicaid for care of people with Alzheimer's and other dementias and the indirect costs to business for employees who are caring for Alzheimer's are estimated at more than $148 billion annually. Learn more. Can It Be Prevented? No treatments or drugs have yet been proven to prevent or delay AD, but people can take some actions that are beneficial for healthy aging and that also might reduce the effect of possible risk factors for AD. You can exercise regularly, eat a healthy diet that is rich in fruits and vegetables, engage in social and intellectually stimulating activities, control type 2 diabetes, lower high blood pressure levels, lower high blood cholesterol levels, and maintain a healthy weight. These actions lower the risk of other diseases and help maintain and improve overall health and well-being, but will not necessarily prevent or delay AD in any one person. Even if these actions were eventually proven effective, they might not offset a person's individual genetic and other risk factors enough to prevent the development of AD. Learn more. What's Being Done About It? Thirty years ago, we knew very little about AD. Since then, scientific research - supported by the National Institute on Aging and other components of the National Institutes of Health, the Alzheimer's Association, and other organizations - has led to important advances in our knowledge about AD and to the development of promising new drugs and treatment strategies. Today, scientists are investigating many approaches to treat, prevent, or cure Alzheimer's, with 91 drugs in clinical trials as of 2008 and more in the pipeline awaiting FDA approval to enter human testing. Learn more. How Can I Help? Clinical trials to test new treatments and interventions are an essential part of AD research. At least 50,000 volunteers, both with and without Alzheimer's, are urgently needed to participate in more than 175 actively enrolling Alzheimer's disease trials and studies in the U.S. To reach that goal, at least half a million volunteers must be screened. To find out more, contact the National Institute on Aging's Alzheimer's Disease Education and Referral (ADEAR) Center at 1-800-438-4380 or at the website www.nia.nih.gov/alzheimers. There are many ways to join the fight against Alzheimer's disease, such as participating in research, supporting people with the disease with donations of time, help, or money, and other activities. To find out more, you can contact the Alzheimer's Association, which invites the public to become "Alzheimer's Advocates," at 1-800-272-3900 or at the website www.alz.org. Need More Information? Visit our collaborators' websites to learn more: National Institute on Aging, National Institutes of Health Alzheimer's Association ******************************************************************************* see more or see the documentary with no subtitiles (by adobe flash player): http://www.hbo.com/alzheimers ******************************************************************************* # Understanding How the Brain Changes Introduction Scientists have said that the human brain is the most complicated organ in the body—in fact, many claim that it is the single most complex natural or man-made entity on our planet. The mighty brain we carry in our heads processes billions of messages a minute, day and night, week after week, year after year, decade after decade. Its knowledge base expands and grows more complex with every new bit of information acquired, making informed decisions and taking creative leaps based on this new input, all the while retaining the older bits. Tens of billions of nerve cells, called neurons, most smaller than a grain of sand, are compressed into an incredibly small space about the size of a cantaloupe. Each has a defined function, carrying out billions of distinct communications as we go through our day. At the same time, outside our awareness, the brain regulates breathing, heartbeat, digestion, sensory organs, excretion, and other functions. The brain is so important that even though it accounts for only 2 percent of our body weight, it receives 20 percent of our blood supply. * Drawing showing damage caused by AD * Doctors track progress by patients clock drawings * Two beta-amyloid plaques surrounded by neurons * The beta-amyloid cascade begins with cutting of APP * * Dr. Ron Petersen * A method of diagnosing AD is cognitive testing * Exercises during cognitive testing * Yet we give little thought to our brain until we encounter a problem in our ability to think. If Alzheimer's disease (AD) develops, the brain slowly loses its ability to make and retrieve memories and process information. A friend's name that was once familiar now eludes us. Last week's Thanksgiving dinner draws a blank. A naval engineer who once performed algebra, calculus, and trigonometry can no longer balance his checkbook. A grandmother cannot recall her family's favorite cookie recipe and is not even safe in the kitchen anymore, as she forgets to shut off the oven. Bits and pieces of life are lost—a doctor's appointment, a child's birth date, the name of a flower, even a spouse's face. Eventually, even simple thinking skills are lost. We don't yet have all the answers about what triggers the cascade of events that eventually leads to AD, or why some changes in memory and thinking skills that occur even in healthy aging become much more destructive in people who have the disease. But we have learned a lot about the major characteristics of the disease and the way in which it develops over time. We also know that the processes in the brain that lead to the physical and behavioral changes in people with AD begin long before anyone is aware that a problem exists—ten to twenty years before significant memory loss occurs. ***************************************************************************** see more or see the documentary with no subtitiles (by adobe flash player): http://www.hbo.com/alzheimers Alzheimer's Disease Organizations around the world: Argentina Asociación de Lucha contra el Mal de Alzheimer Lacarra No 78 1407 Capital Federal, Buenos Aires Argentina Tel/Fax: +54 11 4671 1187 Email: [email protected] /* */ Web: www.alma-alzheimer.org.ar Bolivia Asociación Boliviana de Alzheimer y Otras Demencias Casilla No. 9302 La Paz Bolivia Tel: +591 2249 4143 Email: [email protected] /* */ Chile Corporación Alzheimer Chile Desiderio Lemus 0143 (alt 1400 Av.Peru) Recoleta Santiago, Chile Tel: +56 2 7321 532 Fax: +56 2 777 7431 Email: [email protected] /* */ Web: www.corporacionalzheimer.cl Costa Rica Asociación Costarricense de Alzheimer y otras Demencias Asociadas 991-2070, Sabanilla de Montes de Oca San José 11502 2070 Costa Rica Tel: +905 285 3919 Email: [email protected] /* */ Web: El Salvador Asociacion de Familiares Alzheimer de El Salvador Villavicencio Plaza, Local 2-15 paseo General Escalón y 99 Avenida Norte San Salvador El Salvador Tel: +503 22 644 072 Email: [email protected] /* */ Honduras Asociación Hondureña de Alzheimer Apartado Postal 5005 Tegucigalpa Honduras, C.A. Tel: +504 239 4512 Fax: +504 232 4580 Email: [email protected] /* */ Web: www.ashalz.org Panamá AFA PADEA Via Fernandez de Córdoba, Edificio Julimar, Primer Piso, Oficina #3 Apartado Postal 6-6839 El Dorado Panama Email: [email protected] /* */ República Dominicana Asociacion Dominicana de Alzheimer Apartado Postal # 3321 Santo Domingo Republica Dominicana Tel: +1 809 544 1711 Fax: +1 809 544 1731 Email: [email protected] /* */ USA Alzheimer's Association 225 N Michigan Avenue Suite 1700 Chicago, Illinois 60601 United States of America Tel: +1 312 335 8700 Helpline: 0800 272 3900 Fax: +1 312 335 1110 Email: [email protected] /* */ Web: www.alz.org Venezuela Fundación Alzheimer de Venezuela Calle El Limon, Qta Mi Muñe, El Cafetal Caracas Venezuela Tel: +58 212 414 6129 Fax: +58 212 9859 183 Email: [email protected] /* */ Web: www.alzheimer.org.ve Barbados Barbados Alzheimer's Association Inc PO Box 398 Bridgetown Barbados Tel: +1 246 438 7111 Email: [email protected] /* */ Brasil FEBRAZ - Federação Brasileira de Associaçãoes de Alzheimer CF 542214 e o endereco Rua Frei Caneca, 915 conjunto 2, Sao Paulo, Brazil 01307-003 Tel/Fax: +55 11 3237 0385 Helpline: 0 800 55 1906 Email: [email protected] /* */ Web: www.abraz.com.br Colombia Asociacion Colombiana de Alzheimer y Desordenes Relacionados Calle 69 A No. 10-16 Sante Fe de Bogota D.C. Colombia Tel/Fax: +57 1 521 9401 Email: [email protected] /* */ Ecuador Fundacion Alzheimer Ecuador Centro Medico Pasteur Ave. Eloy Alfaro e Italia 2do Piso. Consultorio 204 Quito Ecuador Tel: +593 2 2521 660 Fax: +593 2 2594 997 Email: [email protected] /* */ Guatemala Asociación ERMITA, Alzheimer de Guatemala 10a. Calle 11-63 Zona 1, Ave. 1-48 Zona 1 Apto B, P O Box 2978 01901 Guatemala Tel: +502 2 320 324 Fax: +502 2 381 122 Email: [email protected] /* */ México Federación Mexicana de Alzheimer Loma Grande 2713, Int. 3 Colonia Lomas de San Francisco Monterrey, N.L. 64710 Mexico Tel: +52 81 8333 6713 or +52 81 8347 4072 Email: [email protected] /* */ Web: www.alzheimerfedma.com Perú Asociación Peruana de Enfermedad de Alzheimer y otras demencias (APEAD) Avenida Arequipa N° 3845 Miraflores Lima 18 Perú Tel./Fax + 511 442 0366 Email: [email protected] /* */ Web: www.alzheimerperu.org Trinidad y Tobago Alzheimer's Association of Trinidad and Tobago c/o Soroptimist International Port of Spain 15 Nepaul Street St James, Port of Spain Republic of Trinidad and Tobago Tel: +1 868 622 6134 Fax: +1 868 627 6731 Email: [email protected] /* */ Uruguay Asociación Uruguaya de Alzheimer y Similares Magallanes 1320 11200 Montevideo Uruguay Tel: +598 2 400 8797 Fax: +598 2 400 8797 Email: [email protected] /* */ Grupo Regional América Latina Alzheimer Iberoamerica C/ Pedro Alcatarena nº 3 Bajo 31014 Pamplona (Navarra) Spain Tel: +34 902 174 517 Fax: +34 948 265 739 Email: [email protected] /* */ ***************************************************************************** (Em Português) The Alzheimer's Project HBO Documentary Capítulo 3 - Assitentes xvid-mp3 Idioma: Inglês Legendas: Português saiba mais: http://www.hbo.com/alzheimer http://www.hbo-br.tv/alzheimer Veja informações a seguir: O Mal de Alzheimer é uma das causas mais devastadoras de perda da memória. Esta doença cerebral irreversível e progressiva lentamente destrói a memória e outras habilidades mentais. Hoje, o Alzheimer é a segunda doença mais temida nos Estados Unidos, depois do câncer, e afeta cerca de 5 milhões de americanos. À medida que a geração “baby boom” for envelhecendo e chegando à aposentadoria, esse número pode pular para mais de 11 milhões em 2040, e causar um enorme impacto econômico no já abalado sistema de assistência médica dos Estados Unidos. Para mais informações em seu país, por favor consulte a entidade ou a Associação Nacional de Alzheimer Brasileira de Alzheimer (www.abraz.com.br). Ainda não há cura para a doença, mas THE ALZHEIMER’S PROJECT (O Projeto Alzheimer) mostra que já existem motivos concretos para ser otimista em relação ao futuro. Criada pela equipe da HBO premiada pelo projeto "Addiction" (Vício), esta série desenvolvida em várias plataformas mostra as descobertas revolucionárias dos maiores cientistas do país e os efeitos desta doença incapacitante e mortal. As pesquisas científicas avançam em busca de tratamentos e de uma possível maneira de evitar o Mal de Alzheimer. Com o objetivo de apresentar o quadro a partir de uma nova perspectiva, a HBO Latin America Group se associou à Alzheimer Iberoamericana – entidade encarregada de coordenar a região da América Latina para conscientizar e promover o conhecimento da doença na região. Também se firmaram acordos de atividades pontuais com entidades locais como: - FEBRAZ - Federação Brasileira de Associações de Alzheimer (www.abraz.com.br) - FEDMA - Federación Mexicana de Alzheimer (http://www.fedma.net/directorio.html ) - Corporación Alzheimer en Chile (www.corporacionalzheimer.cl) - ALMA en Argentina (www.alma-alzheimer.org.ar ) - Asociación Peruana de Enfermedad de Alzheimer y Otras Demencias (www.alzheimerperu.org) Nas atividades desenvolvidas, fez-se um chamado à sociedade para conscientizar sobre a doença, e pôs-se à disposição das diferentes associações e veículos de comunicação o documentário “The Alzheimer Project”. Além disso, a exibição desse e outros documentários nos canais HBO e o uso das diferentes plataformas on-line da HBO (www.hbomax.tv) contribuem para o objetivo de ajudar as pessoas que sofrem de Alzheimer na América Latina. O primeiro dos quatro documentários THE ALZHEIMER'S PROJECT é "The Memory Loss Tapes" (As Fitas Perdidas da Memória), que apresenta uma visão pessoal de sete pessoas com Alzheimer diante do fantasma do avanço da doença. "Momentum In Science" (Impulso da Ciência) leva durante duas horas o espectador para dentro de laboratórios e clínicas de 25 grandes cientistas e médicos, e revela alguns dos maiores progressos das pesquisas. "Grandpa, Do You Know Who I Am?” (Vô, Você Sabe Quem Eu Sou?), com Maria Shriver, mostra o que significa ser filho ou neto de uma pessoa com Alzheimer. "Caregivers" (Cuidadores) destaca os sacrifícios e as vitórias de pessoas que passaram pela experiência de cuidar de alguém muito querido que mergulhava na demência. THE ALZHEIMER'S PROJECT é uma produção da HBO Documentary Films e do National Institute on Aging do National Institutes of Health, em parceria com a Alzheimer's Association, o Fidelity Charitable Gift Fund e a Geoffrey Beene Gives Back Alzheimer's Initiative. A série tem como produtor John Hoffman e como produtores executivos Sheila Nevins e Maria Shriver. ******************************************************************************* O Mal de Alzheimer é uma doença irreversível e progressiva que afeta o cérebro e lentamente destrói a memória e outras habilidades mentais. Pode chegar a anular a capacidade de realizar as tarefas cotidianas mais simples. Atualmente, as vítimas do Mal de Azheimer morrem muitos anos mais cedo do que morreriam sem a doença. A maior parte dos doentes começa a apresentar sintomas depois dos 60 anos. O cérebro dessas pessoas exibe um excesso de duas estruturas anormais — placas de amilóides e novelos neurofibrilares. A terceira característica diferente é a perda de conexões entre as células nervosas (neurônios) no cérebro. A quem afeta? O Mal de Alzheimer é mais comum em pessoas mais velhas. Hoje afeta mais de 5,3 milhões de norte-americanos, segundo estimativas da Alzheimer's Association. À medida que a geração do “baby-boom” for envelhecendo e chegando à aposentadoria, esse número pode pular para mais de 11 milhões em 2040. Uma em cada oito pessoas com 65 anos ou mais sofre da doença. O número de pessoas com Mal de Alzheimer dobra a cada cinco anos de idade a partir dos 65. Quem está no grupo de risco? A idade é o maior fator de risco conhecido. A herança genética também pode influenciar o risco de desenvolver a doença, e em qual momento da vida. Outros fatores não genéticos, ambientais ou de estilo de vida podem influenciar a saúde do cérebro e o desenvolvimento ou a prevenção do Mal de Alzheimer. A maioria deles pode ser controlada ou reduzida com atividades físicas, alimentação saudável, controle de doenças crônicas, relacionamentos sociais e estímulo intelectual. Como é possível diagnosticar a doença? Pessoas com sérios problemas de memória devem procurar um médico. O profissional pode diagnosticar o problema ou encaminhar o paciente para um neurologista ou um psiquiatra geriatra. Profissionais de saúde especializados em Alzheimer podem indicar maneiras de lidar com o problema ou sugerir tratamentos e serviços que podem ajudar. Existe tratamento? Não existe cura para o Mal de Alzheimer, mas os tratamentos atuais têm como objetivo ajudar a preservar as funções mentais, administrar os sintomas comportamentais e retardar o aparecimento dos outros diversos sintomas. Quatro medicamentos para o tratamento da doença foram aprovados pelo FDA, o órgão dos Estados Unidos responsável pelo controle de remédios. Mas essas substâncias não alteram o desenvolvimento da doença; elas podem apenas ajudar durante alguns meses ou poucos anos. Os sintomas comportamentais podem ser acompanhados por problemas de memória e podem incluir insônia, agitação, dispersão, ansiedade, raiva e depressão. Cientistas estão estudando novos tratamentos para lidar com esses quadros. Combater os sintomas comportamentais em geral permite que os doentes vivam melhor e que o cotidiano se torne mais fácil para as pessoas que cuidam deles. Quem mais é afetado? Cerca de 10 milhões de norte-americanos trabalham voluntariamente durante 8,5 bilhões de horas para cuidar de pessoas com Mal de Alzheimer ou outras demências – um tempo que vale 94 bilhões de dólares de acordo com a Alzheimer's Association. Entre as vítimas da doença, 70% moram em casa, cuidadas pela família ou por amigos. O maior grupo de “cuidadores” familiares é formado por esposas, seguido por filhas, noras, filhos, irmãos e netos. Aproximadamente três de cada cinco cuidadores dizem que seus filhos com idades entre 8 e 21 anos estão de alguma forma envolvidos no cuidado de uma pessoa querida com Mal de Alzheimer, segundo uma pesquisa de 2008 da Harris Interactive. Além de parentes e amigos, a sociedade como um todo é afetada. Hoje, o custo direto dos planos de saúde para cuidar de doentes com Mal de Alzheimer e outras demências, além dos custos indiretos para as empresas em função de funcionários com Alzheimer, é estimado em mais de 148 bilhões de dólares por ano. Existe maneira de evitar a doença? Ainda não existem tratamentos nem medicamentos que comprovadamente possam evitar ou retardar o desenvolvimento do Mal de Alzheimer, mas é possível adotar atitudes benéficas para envelhecer com saúde e reduzir o efeito de possíveis fatores de risco. Praticar exercícios físicos regularmente, adotar uma alimentação saudável rica em frutas, verduras e legumes, manter atividades sociais e intelectualmente estimulantes, controlar a diabetes tipo 2, manter a pressão arterial baixa, controlar o colesterol nos níveis adequados e ter o peso indicado são medidas que reduzem o risco de ter outras doenças, e ajudam a manter e a melhorar a saúde em geral e o bem-estar, mas não necessariamente evitam ou retardam o desenvolvimento do Mal de Alzheimer. Mesmo que seja comprovado que essas medidas são efetivas contra a doença, elas podem não ser capazes de combater a propensão genética e outros fatores de risco a ponto de evitar o Mal de Alzheimer. O que vem sendo feito? Há 30 anos, sabia-se muito pouco sobre o Mal de Alzheimer. Mas ao longo desse período pesquisas científicas – promovidas pelo National Institute on Aging e outros órgãos do National Institutes of Health, pela Alzheimer's Association e por outras entidades – levaram a grandes avanços no conhecimento sobre a doença e ao desenvolvimento de novos medicamentos e tratamentos promissores. Hoje, cientistas pesquisam diversas abordagens para tratar, evitar e curar o Mal de Alzheimer, com 91 medicamentos em estudos clínicos até 2008 e outros esperando a aprovação do FDA para serem testados em seres humanos. ***************************************************************************** Argentina Asociación de Lucha contra el Mal de Alzheimer Lacarra No 78 1407 Capital Federal, Buenos Aires Argentina Tel/Fax: +54 11 4671 1187 Email: [email protected] /* */ Web: www.alma-alzheimer.org.ar Bolivia Asociación Boliviana de Alzheimer y Otras Demencias Casilla No. 9302 La Paz Bolivia Tel: +591 2249 4143 Email: [email protected] /* */ Chile Corporación Alzheimer Chile Desiderio Lemus 0143 (alt 1400 Av.Peru) Recoleta Santiago, Chile Tel: +56 2 7321 532 Fax: +56 2 777 7431 Email: [email protected] /* */ Web: www.corporacionalzheimer.cl Costa Rica Asociación Costarricense de Alzheimer y otras Demencias Asociadas 991-2070, Sabanilla de Montes de Oca San José 11502 2070 Costa Rica Tel: +905 285 3919 Email: [email protected] /* */ Web: El Salvador Asociacion de Familiares Alzheimer de El Salvador Villavicencio Plaza, Local 2-15 paseo General Escalón y 99 Avenida Norte San Salvador El Salvador Tel: +503 22 644 072 Email: [email protected] /* */ Honduras Asociación Hondureña de Alzheimer Apartado Postal 5005 Tegucigalpa Honduras, C.A. Tel: +504 239 4512 Fax: +504 232 4580 Email: [email protected] /* */ Web: www.ashalz.org Panamá AFA PADEA Via Fernandez de Córdoba, Edificio Julimar, Primer Piso, Oficina #3 Apartado Postal 6-6839 El Dorado Panama Email: [email protected] /* */ República Dominicana Asociacion Dominicana de Alzheimer Apartado Postal # 3321 Santo Domingo Republica Dominicana Tel: +1 809 544 1711 Fax: +1 809 544 1731 Email: [email protected] /* */ USA Alzheimer's Association 225 N Michigan Avenue Suite 1700 Chicago, Illinois 60601 United States of America Tel: +1 312 335 8700 Helpline: 0800 272 3900 Fax: +1 312 335 1110 Email: [email protected] /* */ Web: www.alz.org Venezuela Fundación Alzheimer de Venezuela Calle El Limon, Qta Mi Muñe, El Cafetal Caracas Venezuela Tel: +58 212 414 6129 Fax: +58 212 9859 183 Email: [email protected] /* */ Web: www.alzheimer.org.ve Barbados Barbados Alzheimer's Association Inc PO Box 398 Bridgetown Barbados Tel: +1 246 438 7111 Email: [email protected] /* */ Brasil FEBRAZ - Federação Brasileira de Associaçãoes de Alzheimer CF 542214 e o endereco Rua Frei Caneca, 915 conjunto 2, Sao Paulo, Brazil 01307-003 Tel/Fax: +55 11 3237 0385 Helpline: 0 800 55 1906 Email: [email protected] /* */ Web: www.abraz.com.br Colombia Asociacion Colombiana de Alzheimer y Desordenes Relacionados Calle 69 A No. 10-16 Sante Fe de Bogota D.C. Colombia Tel/Fax: +57 1 521 9401 Email: [email protected] /* */ Ecuador Fundacion Alzheimer Ecuador Centro Medico Pasteur Ave. Eloy Alfaro e Italia 2do Piso. Consultorio 204 Quito Ecuador Tel: +593 2 2521 660 Fax: +593 2 2594 997 Email: [email protected] /* */ Guatemala Asociación ERMITA, Alzheimer de Guatemala 10a. Calle 11-63 Zona 1, Ave. 1-48 Zona 1 Apto B, P O Box 2978 01901 Guatemala Tel: +502 2 320 324 Fax: +502 2 381 122 Email: [email protected] /* */ México Federación Mexicana de Alzheimer Loma Grande 2713, Int. 3 Colonia Lomas de San Francisco Monterrey, N.L. 64710 Mexico Tel: +52 81 8333 6713 or +52 81 8347 4072 Email: [email protected] /* */ Web: www.alzheimerfedma.com Perú Asociación Peruana de Enfermedad de Alzheimer y otras demencias (APEAD) Avenida Arequipa N° 3845 Miraflores Lima 18 Perú Tel./Fax + 511 442 0366 Email: [email protected] /* */ Web: www.alzheimerperu.org Trinidad y Tobago Alzheimer's Association of Trinidad and Tobago c/o Soroptimist International Port of Spain 15 Nepaul Street St James, Port of Spain Republic of Trinidad and Tobago Tel: +1 868 622 6134 Fax: +1 868 627 6731 Email: [email protected] /* */ Uruguay Asociación Uruguaya de Alzheimer y Similares Magallanes 1320 11200 Montevideo Uruguay Tel: +598 2 400 8797 Fax: +598 2 400 8797 Email: [email protected] /* */ Grupo Regional América Latina Alzheimer Iberoamerica C/ Pedro Alcatarena nº 3 Bajo 31014 Pamplona (Navarra) Spain Tel: +34 902 174 517 Fax: +34 948 265 739 Email: [email protected] /* */

udp://tracker.openbittorrent.com:80
udp://open.demonii.com:1337
udp://tracker.coppersurfer.tk:6969
udp://exodus.desync.com:6969